A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)
Clinical trial NCT03565900 · COMPLETED
Trial details
- NCT number
- NCT03565900
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-12
- Primary completion
- 2021-11-04
- Enrollment
- 277
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.